Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid Cancer

In a recent article, we reported a restorative therapeutic intervention that turned individual thyroid cancer lesions into more efficient tissues for taking up radioactive iodine (RAI), resulting in clinically significant and durable responses. A group of Iodine-131 refractory thyroid cancer patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Larson, Steven M., Osborne, Joseph R., Grewal, Ravinder K., Tuttle, R. Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283711/
https://www.ncbi.nlm.nih.gov/pubmed/28117292
http://dx.doi.org/10.4274/2017.26.suppl.09

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283711/
https://www.ncbi.nlm.nih.gov/pubmed/28117292
http://dx.doi.org/10.4274/2017.26.suppl.09

Ejemplares similares